Patents by Inventor Yunli Zhao

Yunli Zhao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING CANCER BY ADMINISTERING AN EPIGALLOCATECHIN GALLATE COMBINED WITH TYROSINE KINASE INHIBITOR
    Publication number: 20220211662
    Abstract: Disclosed is an application of Epigallocatechin Gallate (EGCG) or a compound synthesized with it as a lead compound in combination with one or more tyrosine kinase inhibitors in preparation of a cancer treatment drug, herein the cancer is an Epidermal Growth Factor Receptor (EGFR) wild-type tumor. This combined use may significantly inhibit the growth of the EGFR wild-type tumor, and reduce the toxic and side effects of an anticancer drug.
    Type: Application
    Filed: May 7, 2019
    Publication date: July 7, 2022
    Inventors: Jun Sheng, Xuanjun Wang, Yanping Huang, Chengting Zi, Zemin Xiang, Yewei Huang, Yunli Zhao, Xiangdan Cuan, Huanhuan Xu, Rui Luo
  • Pharmaceutical composition for treating respiratory disease
    Patent number: 10603345
    Abstract: The invention provides a pharmaceutical composition for treating a respiratory disease, wherein the pharmaceutical composition comprises one or more components selected from picrinine, vallesamine, scholaricine, and 19-epischolaricine. The pharmaceutical composition has a good protective effect on the respiratory system, and can be used in treatment of a relevant disease.
    Type: Grant
    Filed: November 10, 2016
    Date of Patent: March 31, 2020
    Assignees: Kunming Institute of Botany, The Chinese Academy of Sciences, Kunming Beiao Technology Company Limited
    Inventors: Xiaodong Luo, Yunli Zhao, Jianhua Shang, Yaping Liu, Yifen Wang
  • PHARMACEUTICAL COMPOSITION FOR TREATING RESPIRATORY DISEASE
    Publication number: 20180344792
    Abstract: The invention provides a pharmaceutical composition for treating a respiratory disease, wherein the pharmaceutical composition comprises one or more components selected from picrinine, vallesamine, scholaricine, and 19-epischolaricine. The pharmaceutical composition has a good protective effect on the respiratory system, and can be used in treatment of a relevant disease.
    Type: Application
    Filed: November 10, 2016
    Publication date: December 6, 2018
    Applicants: Kunming Institute of Botany, The Chinese Academy of Sciences, Kunming Beiao Technology Company Limited
    Inventors: Xiaodong Luo, Yunli Zhao, Jianhua Shang, Yaping Liu, Yifen Wang